101![Calmodulin in Complex with Proteins and Small Molecule Ligands: Operating with the Element of Surprise. Implications for Structure-Based Drug Design Dóra K.Menyhárd1, György M. Keserű1,2and Gábor Náray-Szabó3,4* 1 Calmodulin in Complex with Proteins and Small Molecule Ligands: Operating with the Element of Surprise. Implications for Structure-Based Drug Design Dóra K.Menyhárd1, György M. Keserű1,2and Gábor Náray-Szabó3,4* 1](https://www.pdfsearch.io/img/0413bbea7d6325b907ad69e256e16e16.jpg) | Add to Reading ListSource URL: real.mtak.huLanguage: English - Date: 2012-02-07 03:29:12
|
---|
102![Synthesis, Structural Elucidation, Biocidal and Preliminary DNA Interaction Studies of Organotin(IV) Complexes with [O,O] and [O,N,O] Donor Ligands ISLAMABAD Synthesis, Structural Elucidation, Biocidal and Preliminary DNA Interaction Studies of Organotin(IV) Complexes with [O,O] and [O,N,O] Donor Ligands ISLAMABAD](https://www.pdfsearch.io/img/af0b5a737cb53b4ecc0ea60df3bfbc1c.jpg) | Add to Reading ListSource URL: prr.hec.gov.pkLanguage: English - Date: 2010-11-15 05:30:35
|
---|
103![Chapter−4 CRYSTALLOGRAPHIC ANALYSIS 4.1 X-ray crystal structure of ligands Chapter−4 CRYSTALLOGRAPHIC ANALYSIS 4.1 X-ray crystal structure of ligands](https://www.pdfsearch.io/img/5fc8327e5699a38e853e2d1242eb167b.jpg) | Add to Reading ListSource URL: prr.hec.gov.pkLanguage: English - Date: 2010-11-15 05:22:34
|
---|
104![Chapter−3 RESULTS AND DISCUSSIONS 3.1 Synthesis of organotin(IV) complexes The organotin(IV) complexes with [O,O] and [O,N,O] potential donor ligands Chapter−3 RESULTS AND DISCUSSIONS 3.1 Synthesis of organotin(IV) complexes The organotin(IV) complexes with [O,O] and [O,N,O] potential donor ligands](https://www.pdfsearch.io/img/7e5e8a13a7657f69303ca6c843a191fc.jpg) | Add to Reading ListSource URL: prr.hec.gov.pkLanguage: English - Date: 2010-11-15 05:22:33
|
---|
105![W138–W142 Nucleic Acids Research, 2005, Vol. 33, Web Server issue doi:[removed]nar/gki357 PEPVAC: a web server for multi-epitope vaccine development based on the prediction of supertypic MHC ligands W138–W142 Nucleic Acids Research, 2005, Vol. 33, Web Server issue doi:[removed]nar/gki357 PEPVAC: a web server for multi-epitope vaccine development based on the prediction of supertypic MHC ligands](https://www.pdfsearch.io/img/bf737ccae9bfcc9801481ff3d85ad5fa.jpg) | Add to Reading ListSource URL: www.ncbi.nlm.nih.govLanguage: English |
---|
106![Hindawi Publishing Corporation Bioinorganic Chemistry and Applications Volume 2014, Article ID[removed], 10 pages http://dx.doi.org[removed][removed]Research Article Hindawi Publishing Corporation Bioinorganic Chemistry and Applications Volume 2014, Article ID[removed], 10 pages http://dx.doi.org[removed][removed]Research Article](https://www.pdfsearch.io/img/b3f018c97a1fbaabeefded6cf48ba41f.jpg) | Add to Reading ListSource URL: downloads.hindawi.comLanguage: English - Date: 2014-08-28 07:57:17
|
---|
107![CONCLUSIONS • Novel [O,O] and [O,N,O] potential donor ligands have been synthesized by the reaction of salicyldehyde and substituted salicyldehydes with tranxemic CONCLUSIONS • Novel [O,O] and [O,N,O] potential donor ligands have been synthesized by the reaction of salicyldehyde and substituted salicyldehydes with tranxemic](https://www.pdfsearch.io/img/bd5053f1132cf17f2ef01ab39f6f04e7.jpg) | Add to Reading ListSource URL: prr.hec.gov.pkLanguage: English - Date: 2010-11-15 05:22:35
|
---|
108![Microsoft Word - Sarangi bh Microsoft Word - Sarangi bh](https://www.pdfsearch.io/img/b8f3b15ed6dccb878a91242dd5bbbdc9.jpg) | Add to Reading ListSource URL: www-ssrl.slac.stanford.eduLanguage: English - Date: 2014-10-31 10:33:38
|
---|
109![Glial cell line-derived neurotrophic factor on porcine oocyte competency and global gene expression Glial cell line-derived neurotrophic factor on porcine oocyte competency and global gene expression](https://www.pdfsearch.io/img/6f1dda1023cb052042d98813b4549401.jpg) | Add to Reading ListSource URL: embryogene.caLanguage: English - Date: 2011-07-07 14:50:54
|
---|
110![Kentucky Intraputamenal GDNF Phase I Clinical Trial John T. Slevin, MD Don M. Gash, PhD Disclosures: None to declare Kentucky Intraputamenal GDNF Phase I Clinical Trial John T. Slevin, MD Don M. Gash, PhD Disclosures: None to declare](https://www.pdfsearch.io/img/2cd0e5e643f31b88e949256449ecf50f.jpg) | Add to Reading ListSource URL: osp.od.nih.govLanguage: English - Date: 2014-01-08 14:44:09
|
---|